Seczole-2 | Film-coated Nitroimidazole Tablets
Each film-coated tablet contains Secnidazole IP in the stated strength. Three separate presentations are listed below.
Secnidazole Tablets IP is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Secnidazole is a long-acting nitroimidazole antimicrobial with activity against susceptible protozoa and anaerobic bacteria. The supplied product range includes film-coated IP tablets in three strengths: 500 mg, 1 g and 2 g (Seczole-2).
Healthy Life Pharma Pvt. Ltd. is identified as the manufacturer and Healthy Inc as the exporter in the supplied product information. Contract manufacturing, supply and registration requirements should be confirmed through an enquiry.
| Presentation | Composition per tablet | Standard | Dosage form |
|---|---|---|---|
| Secnidazole 500 mg | Secnidazole 500 mg | IP | Film-coated |
| Secnidazole 1 g | Secnidazole 1,000 mg | IP | Film-coated |
| Seczole-2 | Secnidazole 2,000 mg | IP | Film-coated |
SKU: Secnidazole Tablets Therapeutic class: Nitroimidazole antibacterial / antiprotozoal. Packaging and shelf life: confirm against approved product specifications.
Key formulation considerations include dose uniformity, tablet size and swallowability for high-strength tablets, taste masking, disintegration, dissolution and suitable moisture-protective packaging. The actual manufacturing processes, excipients and coating systems are batch- and product-specific and require confirmation from the manufacturer.
Appropriate quality control includes identity, assay, content uniformity where applicable, dissolution, related substances, microbial quality and stability testing according to the registered specification. No particular release percentage, shelf life or analytical result is asserted without a certificate of analysis.
Secnidazole may be used for bacterial vaginosis and, in certain jurisdictions, susceptible trichomoniasis, giardiasis and amoebiasis. The indication, dosage form and approved regimen differ by country. It is not suitable for all causes of vaginal discharge or diarrhoea; diagnosis and appropriate treatment are essential.
Mechanism: as a nitroimidazole, secnidazole damages microbial DNA after activation in susceptible organisms.
For B2B procurement, request current product registration status, specifications, stability data, available packaging, certificates and dossier support. WHO-GMP certification, Star Export House status, CTD/ACTD availability and country-specific supply should be independently verified before publication as unconditional claims.
Q: What strengths are listed?
500 mg, 1 g and Seczole-2 2 g, all as film-coated tablets containing Secnidazole IP.
Q: Does a 2 g treatment dose always mean one 2 g tablet?
No. A prescribed total dose and an individual tablet strength are different. The prescriber and the approved product label determine how a dose is supplied and taken.
Q: Is it appropriate for every vaginal infection?
No. Causes vary, and treatment depends on diagnosis and local approval.
Prescription only. The dose, number of tablets and treatment duration depend on the diagnosed infection, age, product approval and local clinical guidance. Some approved secnidazole regimens use a single total dose, but that does not establish an approved regimen for every 500 mg, 1 g or 2 g tablet presentation. Follow the prescribing information; do not self-medicate.
Possible adverse effects include nausea, headache, abdominal discomfort, altered or metallic taste and vaginal yeast infection. Seek medical advice for allergic reactions or neurological symptoms. Discuss pregnancy, breastfeeding, liver disease, other medicines and prior nitroimidazole allergy with a clinician. Alcohol-related advice differs between product labels and jurisdictions; follow the specific approved label rather than assuming a universal restriction.
Keep in the original packaging, protected from excessive moisture and light, and out of reach of children. Follow the storage temperature and expiry date on the approved pack; do not assign an unverified 25°C or 30°C limit.